021-51111890
购物车（）
sales@molnova.cn
Pirozadil
CAS No. 54110-25-7
Pirozadil ( —— )
产品货号. M19963 CAS No. 54110-25-7
Pirozadil 是一种降血脂药。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥599 | 有现货 |
|
| 5MG | ￥988 | 有现货 |
|
| 10MG | ￥1596 | 有现货 |
|
| 25MG | ￥3208 | 有现货 |
|
| 50MG | ￥4771 | 有现货 |
|
| 100MG | ￥6828 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Pirozadil
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Pirozadil 是一种降血脂药。
-
产品描述Pirozadil is a hypolipidemic agent.
-
体外实验——
-
体内实验Pirozadil is a hypolipidemic agent. Pirozadil's effect on increasing cerebral blood flow is almost equal to that of papaverine, less than that of nicardipine and much greater than that of the other hypolipidemic/ antiatherogenic drugs, nicotinic acid and pyridinol carbamate. Pirozadil is also shown to significantly diminish vascular cerebral resistance to a much greater degree than nicotinic acid and pyridinol carbamate.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number54110-25-7
-
分子量527.52
-
分子式C27H29NO10
-
纯度>98% (HPLC)
-
溶解度DMSO: 60 mg/mL need ultrasonic;Water: Insoluble
-
SMILESCOc1cc(cc(OC)c1OC)C(=O)OCc1cccc(COC(=O)c2cc(OC)c(OC)c(OC)c2)n1
-
化学全称26-Pyridinediyldimethylene-bis(345-trimethoxybenzoate)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Masana L et al. Treatment of diet-resistant polygenic hypercholesterolaemic patients with a new nicotinate derivative; in vivo and in vitro low density lipoprotein metabolic studies. J Clin Pharmacol. 1989 Mar;29(3):201-6.
产品手册
关联产品
-
UC-1728
UC-1728 是一种有效的兔可溶性环氧化物水解酶抑制剂（对兔肝脏的IC50：2 nM）。通过皮下注射 sEH 抑制剂（UC1728，3 mg/kg）或载体对照（PEG400）对兔子进行治疗，并使用改良的 Hackett-McDonald 评分系统在前房内 LPS 注射后 6、24 和 48 小时评估葡萄膜炎。
-
Moracin O
Moracin O shows significant neuroprotective, and analgesic activities, it also has a strong protective influence against doxorubicin-induced cardiomyopathy in H9c2 cells with the EC50 value of 4.5 ± 1.3 μM.
-
5'-UMP disodium salt
尿苷 5'-单磷酸二钠盐已用于研究嘧啶合成抑制剂 5-氮杂胞苷对胆固醇和脂质代谢的影响。
